Literature DB >> 18070012

Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.

Antonina Mikocka-Walus1, Deborah Turnbull, Nicole Moulding, Ian Wilson, Jane M Andrews, Gerald Holtmann.   

Abstract

BACKGROUND AND AIM: The prevalence of psychological disorders is high in patients with irritable bowel syndrome (IBS) but their role in symptom reporting is uncertain. It is thus interesting whether the number of functional gastrointestinal disorders (FGID) determines the load of psychological comorbidity. The Rome III criteria have not been used to evaluate such a relationship as yet. Moreover, not many studies have examined the sensitivity of the Rome III criteria in detecting IBS. Our aims were therefore: (i) to determine whether those IBS participants with more FGID had a tendency to greater psychological comorbidity than those with fewer FGID; and (ii) to assess the performance of the Rome III criteria in detecting IBS versus the diagnosis of the gastroenterologist.
METHODS: A cross-sectional survey of 32 consecutive outpatients with clinically diagnosed IBS was performed. The Hospital Anxiety and Depression Scale (HADS), the Short Form 12 Health Survey (SF-12), and the Rome III criteria questionnaire (BDQ-6) were administered. Multiple linear regression was conducted to detect associations among FGID, anxiety, depression and quality of life.
RESULTS: Overall, 50% of participants were anxious and 12% were depressed. Forty-four percent of participants had >two FGID; however, the number of FGID did not correlate with scores for anxiety, depression or quality of life. Amazingly, only 50% (CI: 33-67) of participants clinically diagnosed with IBS met Rome III criteria for IBS.
CONCLUSION: Contrary to our expectations, a greater load of FGID did not correlate with a greater load of psychological comorbidity. Surprisingly, the Rome III criteria detected only 50% of clinical cases of IBS.

Entities:  

Mesh:

Year:  2007        PMID: 18070012     DOI: 10.1111/j.1440-1746.2007.05245.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

2.  Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.

Authors:  Maria Ines Pinto-Sanchez; Alexander C Ford; Christian A Avila; Elena F Verdu; Stephen M Collins; David Morgan; Paul Moayyedi; Premysl Bercik
Journal:  Am J Gastroenterol       Date:  2015-05-12       Impact factor: 10.864

3.  Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome.

Authors:  Prashant Singh; Sarah Ballou; Jesse Katon; Eve Takazawa; Vikram Rangan; Rupa Mukherjee; Johanna Iturrino; Judy Nee; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-11       Impact factor: 11.382

4.  Pelvic floor disorders and quality of life in women with self-reported irritable bowel syndrome.

Authors:  J Wang; M G Varma; J M Creasman; L L Subak; J S Brown; D H Thom; S K van den Eeden
Journal:  Aliment Pharmacol Ther       Date:  2009-10-23       Impact factor: 8.171

5.  Role of psychiatric disorders and irritable bowel syndrome in asthma patients.

Authors:  Ayse Yilmaz; Birgul Elbozan Cumurcu; Turker Tasliyurt; Abdulkadir Geylani Sahan; Yusuf Ustun; Ilker Etikan
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study.

Authors:  Daria Piacentino; Rosanna Cantarini; Marianna Alfonsi; Danilo Badiali; Nadia Pallotta; Massimo Biondi; Enrico S Corazziari
Journal:  BMC Gastroenterol       Date:  2011-08-26       Impact factor: 3.067

7.  Are They Side Effects? Extraintestinal Symptoms Reported During Clinical Trials of Irritable Bowel Syndrome May Be More Severe at Baseline.

Authors:  Sarah Ballou; Rafla Hassan; Judy Nee; Johanna Iturrino; Vikram Rangan; Vivian Cheng; Lisa Conboy; Irving Kirsch; Anthony Lembo; Ted J Kaptchuk; John Kelley
Journal:  Clin Gastroenterol Hepatol       Date:  2022-03-23       Impact factor: 13.576

8.  Psychological features in patients with and without irritable bowel syndrome: A case-control study using Symptom Checklist-90-Revised.

Authors:  Fadai Farbod; Neda Farzaneh; Moghimi-Dehkordi Bijan; Ghobakhlou Mehdi; Naderi Nosratollah
Journal:  Indian J Psychiatry       Date:  2015 Jan-Mar       Impact factor: 1.759

9.  A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment.

Authors:  Eldin Jašarević; Ali B Rodgers; Tracy L Bale
Journal:  Neurobiol Stress       Date:  2015-01-01

Review 10.  Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.

Authors:  Rachel D Moloney; Siobhain M O'Mahony; Timothy G Dinan; John F Cryan
Journal:  Front Psychiatry       Date:  2015-02-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.